Coenzyme Q10 Market Is Expected to See 9% CAGR by 2024: Pharmavite, SourceOne Healthcare Technologies, Kaneka North America and Tishcon Corp
Global Coenzyme Q10 Market is is anticipated to exceed USD 1.5 billion by 2024, owing to its favorable application overview for treating ailments such as cancer, cognitive illness, Parkinson’s syndrome, periodontal, neurological disease, kidney failure, cardiovascular disease, and Huntington’s disease.
View full press release